AbstractBisphosphonate-associated osteonecrosis of the jaws (BRONJ) may have significant morbidities ranging from minimal discomfort to significant loss of function. We report a case of jaw osteonecrosis resulting from long-term use of bisphosphonate. An 83-year-old female, a long-term user of alendronate, developed jaw osteonecrosis without a history of recent dental extraction. Facial bone computed tomography of the patient showed a destructive osteolytic change of the whole right mandible bone with adjacent soft tissue swelling. After surgical debridement, antibiotic treatment, and discontinuation of alendronate, the patient recovered very well. Although uncommon, BRONJ has gained extensive attentions. Physicians should be aware of the p...
Abstract Introduction Osteonecrosis of the jaw is a serious side effect in patients receiving nitrog...
Bisphosphonates are associated with osteonecrosis of the jaw (ONJ) that is defined as an area of exp...
Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of a...
AbstractBisphosphonate-associated osteonecrosis of the jaws (BRONJ) may have significant morbidities...
Background: In recent years, more and more evidence has demonstrated that a rare symptom, osteonecro...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an adverse drug reaction described as the...
Bisphonates are used widely to treat osteoporosis, hyperglycemia of malignancy, bone metastasis of s...
BACKGROUND Osteoporosis affects millions of elderly patients. Bisphosphonates represent first-line ...
SummaryBackgroundIn recent years, more and more evidence has demonstrated that a rare symptom, osteo...
Bisphosphonates are becoming increasingly important in the treatment of metabolic and oncological di...
Abstract: Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is characterized as exposed bone ...
Bisphosphonates are used to reduce skeletal-related events in patients with bone-consuming diseases,...
Clinical importance of the bisphosphonate-related osteonecrosis of the jaw (BRONJ) which is one of t...
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio ...
Background: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of oste...
Abstract Introduction Osteonecrosis of the jaw is a serious side effect in patients receiving nitrog...
Bisphosphonates are associated with osteonecrosis of the jaw (ONJ) that is defined as an area of exp...
Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of a...
AbstractBisphosphonate-associated osteonecrosis of the jaws (BRONJ) may have significant morbidities...
Background: In recent years, more and more evidence has demonstrated that a rare symptom, osteonecro...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an adverse drug reaction described as the...
Bisphonates are used widely to treat osteoporosis, hyperglycemia of malignancy, bone metastasis of s...
BACKGROUND Osteoporosis affects millions of elderly patients. Bisphosphonates represent first-line ...
SummaryBackgroundIn recent years, more and more evidence has demonstrated that a rare symptom, osteo...
Bisphosphonates are becoming increasingly important in the treatment of metabolic and oncological di...
Abstract: Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is characterized as exposed bone ...
Bisphosphonates are used to reduce skeletal-related events in patients with bone-consuming diseases,...
Clinical importance of the bisphosphonate-related osteonecrosis of the jaw (BRONJ) which is one of t...
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio ...
Background: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of oste...
Abstract Introduction Osteonecrosis of the jaw is a serious side effect in patients receiving nitrog...
Bisphosphonates are associated with osteonecrosis of the jaw (ONJ) that is defined as an area of exp...
Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of a...